---
title: "Undervalued healthcare stocks with attractive valuation grades"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299081544.md"
description: "Seeking Alpha highlights 11 undervalued healthcare stocks based on quantitative Valuation Grades. Led by Centene (CNC), Harmony Biosciences (HRMY), and Pfizer (PFE) with A+ grades, the list includes BioCryst (BCRX), Cigna (CI), CVS Health (CVS), and Molina Healthcare (MOH) at A grades. Alignment Healthcare (ALHC), Bristol-Myers Squibb (BMY), DaVita (DVA), and Tenet Healthcare (THC) hold A- grades. These rankings assess stock expensiveness relative to fundamentals, identifying potential investment opportunities in managed care, pharma, and biotech sectors."
datetime: "2026-09-15T17:28:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299081544.md)
  - [en](https://longbridge.com/en/news/299081544.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299081544.md)
generator: "portal-rs"
---

# Undervalued healthcare stocks with attractive valuation grades

Healthcare stocks continue to attract investor attention as managed care providers, pharmaceutical companies, biotechnology firms and healthcare services businesses navigate changing demand and industry conditions. With valuations varying significantly across the sector, stocks trading at discounts to their underlying fundamentals can offer potenti...

### Related Stocks

- [ALHC.US](https://longbridge.com/en/quote/ALHC.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [BCRX.US](https://longbridge.com/en/quote/BCRX.US.md)
- [CI.US](https://longbridge.com/en/quote/CI.US.md)
- [HRMY.US](https://longbridge.com/en/quote/HRMY.US.md)
- [THC.US](https://longbridge.com/en/quote/THC.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [DVA.US](https://longbridge.com/en/quote/DVA.US.md)
- [MOH.US](https://longbridge.com/en/quote/MOH.US.md)
- [CNC.US](https://longbridge.com/en/quote/CNC.US.md)
- [CVS.US](https://longbridge.com/en/quote/CVS.US.md)

## Related News & Research

- [Will Conference Outlook Change Pfizer (PFE) Stock Narrative](https://longbridge.com/en/news/299537947.md)
- [Pfizer Refocuses Growth Strategy as New Products Offset COVID Decline](https://longbridge.com/en/news/299762807.md)
- [Wall Street's bull case for Bristol Myers Squibb is getting louder](https://longbridge.com/en/news/299558994.md)
- [Bristol-Myers Squibb announces R$ 2.15-per-unit dividend for Q4 2026](https://longbridge.com/en/news/299364494.md)
- [Bristol Myers Squibb’s Psoriatic Arthritis Pill Shows Durable Efficacy After Two Years](https://longbridge.com/en/news/299344764.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**